← All Platforms

Gentian Diagnostics

research
IVD reagent manufacturing — immunoassays for clinical chemistry analyzers (human and veterinary) · Publicly listed Oslo Bors (GENT); major shareholders Runar Vatne (15%), Kvantia/Andenas family (13%) · NO · 4 locations
https://www.gentian.com
OwnerUnassigned
Prep →
ICP Score
33
Deal Value
$60K
Contacts (0)
No contacts identified yet
Signals (0)
No signals captured
Engagements (0)
No engagements recorded
Gentian Diagnostics · research